Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Assets (2021 - 2025)

Medicinova (MNOV) has disclosed Assets for 8 consecutive years, with $45.6 million as the latest value for Q4 2025.

  • Quarterly Assets changed N/A to $45.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.6 million through Dec 2025, changed N/A year-over-year, with the annual reading at $45.6 million for FY2025, N/A changed from the prior year.
  • Assets for Q4 2025 was $45.6 million at Medicinova, down from $47.6 million in the prior quarter.
  • The five-year high for Assets was $96.1 million in Q1 2021, with the low at $45.6 million in Q4 2025.
  • Average Assets over 5 years is $70.2 million, with a median of $68.4 million recorded in 2023.
  • The sharpest move saw Assets dropped 11.58% in 2024, then decreased 18.14% in 2025.
  • Over 5 years, Assets stood at $87.4 million in 2021, then dropped by 10.31% to $78.4 million in 2022, then decreased by 15.46% to $66.3 million in 2023, then dropped by 12.3% to $58.1 million in 2024, then dropped by 21.54% to $45.6 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $45.6 million, $47.6 million, and $49.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.